Cross-Sector entity
Of the tracked stories, 10 of 20 also mention Citigroup, the most common co-covered peer. Across a 174-day span, the pace is roughly 0.8 stories per week. The busiest single day carried 3. markets accounts for 9 of the 20 tracked stories, while 8 other categories carry the remainder.
20 verified stories tracked
Last mentioned: Aug 13, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Of the tracked stories, 10 of 20 also mention Citigroup, the most common co-covered peer. Across a 174-day span, the pace is roughly 0.8 stories per week. The busiest single day carried 3. markets accounts for 9 of the 20 tracked stories, while 8 other categories carry the remainder. 0% of these stories carry negative sentiment. Wells Fargo & Company appears in 20 tracked Cross-Sector stories published from February 21, 2026 through August 13, 2026. The tracked stories average 2.2 original sources each.
Computed from the 20 stories linked to this entity. Beat comparisons are omitted because no baseline was available for this window.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Wells Fargo & Company. Shared-story counts are live from our verified record — not editorial picks.
Dividend Payment Date
Quarterly dividend paid to shareholders of record July 24.
Wall Street Zen cuts STAG and ZVIA to Sell
Wall Street Zen downgraded both Stag Industrial and Zevia PBC from hold to sell in weekend research notes.
ZVIA reports Q2 results
Zevia PBC reported EPS of -$0.03, hitting consensus, and revenue of $45.00 million versus a $44.21 million estimate.
Weiss reiterates buy on STAG; Baird sets $138 target
Weiss Ratings reiterated a buy (b-) rating on Stag Industrial, while Robert W. Baird set a $138.00 target price.
STAG reports Q2 earnings miss
Stag Industrial reported EPS of $0.28, missing the consensus estimate of $0.65 by $0.37; revenue was approximately $224 million.
Dividend Record Date
Shareholders of record qualify for $0.77 quarterly dividend.
Q2 Earnings Release
Kaiser Aluminum reports EPS $5.53, beats estimates by $2.87; revenue $1.26B surpasses $1.12B estimate.
Weiss Ratings upgrades ZVIA within sell range
Weiss Ratings raised shares of Zevia PBC from a sell (e+) rating to a sell (d-) rating.
Barclays raises STAG target but stays Underweight
Barclays boosted its price objective on Stag Industrial from $38.00 to $41.00 and maintained an underweight rating.
Wells Fargo Reaffirms Underweight
Wells Fargo reiterates underweight rating, sets $158 price target.
Wells Fargo Cuts Target to $70
Wells Fargo & Company lowers Freshpet’s price target from $75.00 to $70.00, keeping an Overweight rating, implying 28.42% upside.
UBS Lifts Price Target
UBS raises Kaiser Aluminum target to $179 from $176, maintains neutral rating.
Bank of America Lowers Target
Bank of America reduces its price target from $75.00 to $70.00 and maintains a Neutral rating.
Stock surges 8.6%
Price hit $14.43 during session, closing at $14.38 on very light volume.
Piper Sandler Stays Overweight
Piper Sandler reaffirms an Overweight rating on Freshpet shares.
Wall Street Zen upgrades to hold
Wall Street Zen lifted its rating from sell to hold.
Weiss Ratings Downgrades
Weiss Ratings cuts Freshpet from 'Hold (c)' to 'Hold (c-)'.
Wells Fargo cuts STAG target to $40
Wells Fargo & Company lowered its target price on Stag Industrial from $41.00 to $40.00 and set an equal weight rating.
Caisse sells 2.15M ZVIA shares
Major shareholder Caisse de dépôt et placement du Québec sold 2,150,000 shares of Zevia PBC at an average price of $1.90, totaling $4.085 million, reducing its stake by 15.87%.
Zacks upgrades to hold
Zacks Research raised the stock from strong sell to hold.
Wall Street Zen cut Stag Industrial to sell, putting a fresh bearish tilt on a REIT whose shares opened at $36.68 versus a $50.50 consensus target. The same firm also downgraded Zevia PBC as its major shareholder trimmed a 15.87% stake.
Source: tickerreport.com · dailypolitical.com
SoFi Technologies shares jumped 3.7% on August 4, 2026, even as multiple analysts slashed price targets, creating a tension between market momentum and cautious research. With a PE of 38.96, beta of 2.17, and consensus Hold rating, the fintech’s next move hinges on whether profitability can catch up with valuation.
Source: tickerreport.com · dailypolitical.com
Wells Fargo lowered Check Point's target to $130, highlighting a divided analyst community with an average target of $149.48. The stock's depressed valuation and low beta present a potential value opportunity against high-growth cyber peers.
Source: dailypolitical.com · themarketsdaily.com
HC Wainwright and Needham lowered price targets on Circle Internet Group but maintained Buy ratings as analysts remain split on the stablecoin issuer. The stock trades at $63.48, far below the consensus target of $100.06, highlighting both opportunity and risk.
Two investment banks cut their price targets on Circle Internet Group, the firm behind the USDC stablecoin, citing near-term headwinds—but both maintained Buy ratings with triple-digit upside potential. The stock’s deep pullback from its $189 high reflects broader crypto market caution.
Source: Bbns · The Lincolnian Online
The 8.6% jump in Smith Douglas Homes stock to $14.38, despite analyst caution and low volume, may signal shifting sentiment in the homebuilding sector that directly impacts PropTech adoption and innovation. For real estate technology stakeholders, the move underscores the interconnectedness of traditional construction and emerging digital solutions.
Source: dailypolitical.com · tickerreport.com
Wabtec guided revenue between $12.3-$12.6B and EPS slightly below the Street, while Moody’s EPS range also came in under estimates. Analysts remain constructive with moderate buy ratings and double-digit upside targets for both stocks.
Source: Bbns · Markets Daily
Kaiser Aluminum's Q2 2026 EPS of $5.53 blasts past estimates by 108%, with revenue reaching $1.26B. Despite the beat, the stock slipped 0.03% to $164.32 amid insider sales and mixed analyst targets. The $0.77 quarterly dividend and strong liquidity ratios offer some reassurance.
Source: MarketBeat · themarketsdaily.com
Analyst downgrades reflect growing fears that GLP-1 weight loss drugs could erode the sleep apnea device market, even as ResMed’s financials stay solid. The contrast between a $225 low target and $321 high target underscores sector uncertainty.
Wells Fargo’s $225 target is the lowest among major banks, yet ResMed’s average analyst target of $270.64 implies a 23.2% upside. Markets weigh defensive balance sheet qualities against emerging therapeutic competition.
Biotech and life sciences investors face a paradox: ResMed’s stalwart medical device business is underpinned by low debt and high margins, yet analyst targets range from $225 to $321 as GLP-1 therapies threaten its patient base.
Source: Ticker Report · Watch List News
Wells Fargo lowered its price target on Freshpet to $70 from $75 while maintaining an Overweight rating, implying the stock is undervalued by 28%. The market remains skeptical with FRPT trading at $54.51, well below the consensus analyst target of $74.25. Analysts overall rate the pet food company a Moderate Buy, despite a string of recent target cuts.
Source: Watch List News · Ticker Report
Raleigh Capital Management increased its Verizon position by a third in Q1 2026, joining other small institutional buyers. Despite VZ's recent price weakness and mixed analyst views, the defensive telecom's high dividend yield and 62% institutional ownership remain draws for income-focused portfolios.
Source: Ticker Report · Daily Political
CoreWeave, a vital GPU cloud provider for AI workloads, saw its stock plunge 48% from its high as a top insider sold $19M in shares. With revenue surging 111.6% but the company deeply leveraged at 3.68 D/E, the AI infrastructure boom faces a reality check.
Brannin Mcbee, a top CoreWeave insider, sold $19M worth of shares across two days under a 10b5-1 plan, reducing his stake by a combined 50.67% as the stock sits 48% below its peak. The sales highlight the delicate dance of founder and executive liquidity in the AI infrastructure startup space.
Maplebear (Instacart) saw an unusual surge in put option volume on Monday, with 8,267 contracts traded—a 144% increase—signaling bearish bets on the grocery delivery giant. Despite strong revenue growth and raised analyst targets, the options activity hints at market caution. Here's what it means for retail and e-commerce investors.
Source: MarketBeat · MarketBeat
Wells Fargo has lowered its rating on O-I Glass (NYSE: OI) from Overweight to Equal Weight, signaling a more cautious stance on the glass packaging giant. The move reflects broader industry challenges and a shift in analyst expectations regarding the company's near-term growth trajectory.
Source: tickerreport.com · dailypolitical.com
AxoGen (NASDAQ: AXGN) has received a major boost from Wall Street as Wells Fargo upgraded the nerve-repair specialist to a 'Strong-Buy' rating. The upgrade follows a significant price target hike from Jefferies, signaling a robust consensus on the company's growth potential in the medical technology sector.
Wells Fargo has upgraded AxoGen (NASDAQ: AXGN) to a 'Strong-Buy' rating, reflecting growing institutional confidence in the company's leadership in peripheral nerve repair. The upgrade follows a significant price target increase from Jefferies and a reaffirmed 'Market Outperform' rating from Citigroup.
AxoGen (NASDAQ: AXGN) has received a significant rating upgrade to "Strong-Buy" from Wells Fargo, signaling robust institutional confidence in the peripheral nerve repair specialist. This move, coupled with price target hikes from Jefferies and positive outlooks from Citigroup, underscores a bullish sentiment for the company's clinical and commercial trajectory.
Source: Ticker Report · Watch List News
